Alfacalm Soft Capsules 1 Microgram (Alfacalcidol)

Adult dose

Chronic kidney disease and osteoporosis: Administer 0.5 to 1 µg once daily as Alfacalcidol. Hypoparathyroidism and other diseases related to vitamin D metabolism abnormalities: Administer 1 to 4 µg once daily as this medication.

Child dose

For osteoporosis: Administer 0.01 to 0.03 µg/kg body weight once daily as Alfacalcidol. For other conditions: Administer 0.05 to 0.1 µg/kg body weight once daily as this medication.

This medication should not be taken by individuals with abnormally high levels of calcium, phosphorus, or magnesium in the blood. Additionally, individuals with excessively alkaline blood or symptoms of vitamin D overdose should not take it. During the use of this medication, it is advisable not to take magnesium-containing preparations, vitamin D or its derivatives, calcium-containing preparations, and diuretics concurrently. These substances may interact with this medication and increase the risk of side effects or elevated blood calcium levels. Women who are breastfeeding should preferably avoid taking this medication as its safety has not been sufficiently established; if it is essential to take it, breastfeeding should be avoided. Women who are pregnant or may become pregnant should only take it after consultation with a physician, as there is a risk of harm to the fetus. Children, the elderly, individuals with a history of kidney stones, or those taking specific medications should also consult with a specialist before using this medication. If symptoms such as appetite loss, nausea, vomiting, muscle spasms, headaches, dizziness, abnormal heart rhythms, renal abnormalities, skin rashes, or ocular symptoms occur while taking this medication, it is necessary to stop taking it immediately and consult medical personnel. Serum calcium levels should be monitored regularly to ensure they remain within the normal range, and emergency treatment may be needed in cases of overdose. If an overdose is suspected, discontinue the medication immediately and visit a healthcare facility.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rashes with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, difficulty breathing or severe shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and severe headaches.

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• stomach pain
• abdominal discomfort
• bloating
• indigestion
• thirst

This medication is sensitive to light; it should be stored in a container that blocks light. It is also advisable to store it at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the medication's efficacy and safety.

Appearance

Brown oval soft capsules containing colorless to transparent or light yellow oily solution.

Package unit

30 capsules/box [(10 capsules/PTP)X3], 60 capsules/box [(10 capsules/PTP)X6], 90 capsules/box [(10 capsules/PTP)X9]